Robert Spurr - 18 Jan 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
U.S. President-Pharma Business
Signature
/s/ Christina Ackermann, attorney-in-fact for Robert A.Spurr
Issuer symbol
BHC
Transactions as of
18 Jan 2022
Net transactions value
-$86,574
Form type
4
Filing time
20 Jan 2022, 18:55:17 UTC
Previous filing
05 Oct 2021
Next filing
17 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Sale $86,574 -3,251 -4.9% $26.63 63,550 18 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.

Remarks:

Exhibit 24 - Power of Attorney